A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)

McMurray, John JV; DeMets, David L; Inzucchi, Silvio E; Køber, Lars; Kosiborod, Mikhail N; Langkilde, Anna M; Martinez, Felipe A; Bengtsson, Olof; Ponikowski, Piotr; Sabatine, Marc S; +53 more... Sjöstrand, Mikaela; Solomon, Scott D; Nicolau, Jose; Diez, Mirta; Katova, Tzvetana; O’Meara, Eileen; Ge, Junbo; Belohlavek, Jan; Schou, Morten; Böhm, Michael; Merkely, Bela; Chopra, Vijay; Kitakaze, Masahumi; De Boer, Rudolf; Drozdz, Jaroslaw; Tereshchenko, Sergey; Dukat, Andrej; Ljungman, Charlotta; Chiang, Chern‐En; Petrie, Mark; Desai, Akshay; Pham, Vinh Nguyen; Pfeffer, Marc A; Pocock, Stuart; Swedberg, Karl; Rouleau, Jean L; Chaturvedi, Nishi; Ivanovich, Peter; Levey, Andrew S; Christ‐Schmidt, Heidi; Held, Claes; Varenhorst, Christoph; Christersson, Christina; Mann, Johannes; Holmgren, Pernilla; Hallberg, Theresa; Langkilde, AnnaMaria; Sjöstrand, Mikaela; Denison, Hans; Reicher, Barry; Bengtsson, Olof; Fox, Ywonne; Forsby, Mikael; Alenhag, Eva‐Lena; Nilsson, Ann; Kazanowska, Kinga; Olofsson, Eva Lavik; Karup, Cathrine; Ekedahl‐Berggren, Maria; Klockargård, Anna‐Lena; Kempe, Karin; Selvén, Mathilda; DAPA-HF Committees and Investigators; (2019) A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF). European Journal of Heart Failure. ISSN 1388-9842 DOI: https://doi.org/10.1002/ejhf.1432

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1002/ejhf.1432

Abstract

Share

Download

Filename: McMurray_et_al-2019-European_Journal_of_Heart_Failure.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar